| Literature DB >> 33519094 |
Zhenfang Zhang1, Dongxiao Ji1, Haijun He2, Seeram Ramakrishna1.
Abstract
The outbreak of Coronavirus Disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has triggered great global public health concern. Face masks are essential tools to reduce the spread of SARS-CoV-2 from human to human. However, there are still challenges to prolong the serving life and maintain the filtering performance of the current commercial mask. Filters composed of ultrafine fibers with diameter down to tens of nanometers have the potential to physically block viruses. With adjustable composition and nanostructures, the electrospun ultrafine fiber filter is possible to achieve other necessary functions beyond virus blocking, such as antiviral, transparent, and degradable, making it an important part of fighting the epidemic. In this review, beginning with the basic information of the viruses, we summarize the knowledge of masks and respirators, including the filtering mechanism, structure, classification, and standards. We further present the fabrication method, filtering performance, and reusable potential of electrospun ultrafine fiber-based masks. In the end, we discuss the development directions of ultrafine fibers in protective devices, especially their new functional applications and possible contributions in the prevention and control of the epidemic.Entities:
Keywords: COVID-19; Filtering mechanism; Mask; Nanofibers; Respirator; Reusable mask; SARS-CoV-2; Virus
Year: 2020 PMID: 33519094 PMCID: PMC7836643 DOI: 10.1016/j.mser.2020.100594
Source DB: PubMed Journal: Mater Sci Eng R Rep ISSN: 0927-796X Impact factor: 36.214
Representative human-to-human transmission viruses in recent years.
| Virus name | Origin | Characteristics | Case-fatality rate/Harm | Prophylaxis or vaccine | Human-to-human transmission | Transmission method | First breakout | Epidemic areas |
|---|---|---|---|---|---|---|---|---|
| Ebola virus | Unknown | RNA virus, 80 nm in diameter, length up to 14,000 nm | 50%-90% | No | Yes | Direct contact blood, fluid of the patient | Africa in 1976 | Africa |
| A(H1N1) virus | Pig | RNA virus, 120 nm in diameter | 6.77% | No | Yes | Droplet and contact transmission | Mexico or USA in 2009 | Worldwide |
| SARS-CoV-1 | Chrysanthemum bat | RNA virus, 60−220 nm in diameter | 14% | No | Yes | Droplet and contact transmission | China in 2003 | Worldwide |
| HIV | Gorilla and chimpanzee | RNA virus, 120 nm in diameter | Almost 100% | No | Yes | Sexual contact across mucosal surfaces, maternal-infant exposure, percutaneous inoculation | USA in 1981 | Worldwide |
| SARS-CoV-2 | Unknown | RNA virus, 60−140 nm in diameter | 3%−5% | No | Yes | Droplet and contact transmission | China in 2019 | Worldwide |
| Zika virus | Unknown | RNA virus, 20 nm in diameter | Infants with microcephaly | No | No | Aedine mosquitoes | Africa in 1947 | Worldwide (Mainly in Brazil) |
| Marburg virus | Unknown | RNA virus, 800−14000 nm in length | 25%∼100% | No | Yes | Contact transmission | Africa in 1967 | Worldwide |
| MERS-CoV | Unknown | RNA virus, 120−160 nm in diameter | 35% | No | Yes (difficult) | Contact transmission | Saudi Arabia in 2012 | Mainly in Saudi Arabia, Arab emirates, Korea |
Fig. 1The structure of SARS-CoV-2. Reproduced with permission from [44]. Copyright 2020, http://www.seebio.cn/Article/1_1.html.
The major international mask and respirator standards.
| Device name | Splash resistance | Type of protection | Filter performance | Equivalent classes | Fit-test | Standards |
|---|---|---|---|---|---|---|
| Medical face mask | NO | Droplets | Variable | Level 1/Type I/ Type II | Not needed | YY/T0969−2013(China) |
| YES | Level 2/ Level 3/ /Type IIR | YY0469−2011(China) | ||||
| Respirator | YES | Droplets and airborne particles | Needed | Class 1/ Class 2/Class 3 | ||
| ≥80% | FFP1 | GB 19083−2010 (China)/ | ||||
| ≥94% | Class1/FFP2/N95/P95/R95 | Level 1/Level 2/Level 3/N95/N99/N100/P96/P99/P100/R95/R99/R100: | ||||
| ASTMF2100−2019(US) | ||||||
| ≥99% | Class2/Class3/FFP3/N99/N100/P99/P100/R99/R100 | Type I/ Type II/ Type IIR/FFP1/FFP2/FFP3: | ||||
| EN14683−2019(UN) | ||||||
| NO | Droplets and airborne particles | ≥80% | FFP1/DL1/ DS1/KF80 | KN90/KN95/KN100 | ||
| KP90/KP96/KP100: | ||||||
| GB 2626−2006(China) | ||||||
| ≥90% | KN90/ KP90 | |||||
| ≥94% | KN95 /N95/FFP2 / DL2/ DS2/ P2/ R95/ KP95/P95 | FFP1/ FFP2/ FFP3: EN 149−2001(UN) | ||||
| ≥99% | N99/FFP3/KF99/ R99/ KF99/ P99 | N95/N99/N100 /R95/R99/R100/P95/P99/P100: | ||||
| ≥99.97% | KN100/N100/ R100/ KP100/P100/ DL3/ DS3/P3 | CFR 42−84-1995(US) | ||||
| DS1/DS2/DS3/DL1/DL2/DL3: | ||||||
| JIS T 8151−2018 (Japan) | ||||||
| KF80: KS M 6673−2008(Korea) | ||||||
| AS/NZS 1716−2012 (Australia/New Zealand) |
The testing methods of surgical mask and respirator.
| Test index | Definition | Test methods |
|---|---|---|
| Bacterial Filtration Efficiency (BFE) (BS EN 14683−2019/ ASTM 2101) | The effectiveness in preventing the passage of aerosolized bacteria, expressed in the percentage of a known quantity that does not pass the medical face mask material at a given aerosol flow rate. | The test works by shooting an aerosol with a liquid suspension of Staphylococcus aureus bacterial at the mask at 28.3 L per minute. Challenge controls are maintained at 1700−2700 colony forming units (CFU) with a mean particle size of 3 ± 0.3 μm. |
| Differential Pressure (Breathability) (BS EN 14683−2019/ GB 19083−2010) | Air permeability of the mask, measured by determining the difference of pressure across the under specific conditions of air flow, temperature and humidity. | To ensure the mask will hold its shape and have proper ventilation while the wearer breathes, breathing resistance is tested by shooting a flow of air at it, then measuring the difference in air pressure on both sides of the mask by a water-filled differential manometer. |
| Splash Resistance (ISO 22609−2004/ ASTM F1862) | Ability of a medical face mask to withstand penetration of synthetic blood projected at a given pressure. | A volume of synthetic blood is sprayed horizontally at the specimen to simulate the scenario of a mask being splashed by a punctured blood vessel to ensure the liquid cannot penetrate and contaminate the wearer. |
| Particulate Filtration Efficiency (PFE) (ASTM F 2299/ EN 149−2001) | The efficiency of the filter material in capturing aerosolized particles smaller than one micron, expressed as the percentage of a known number of particles that does not pass the medical face mask material at a given flow rate. | Also known as the latex particle challenge, this test involves spraying an aerosol of polystyrene microspheres at 28.3 L per minute to ensure the mask can filter the size of the particle it’s supposed to. |
| Flammability (16 CFR Part 1610) | The characteristics of a material that pertain to its relative ease of ignition and relative ability to sustain combustion. | Since several elements of an operating room can easily cause fire, the surgical masks are tested for flammability by being set on fire to measure how slowly it catches and how long the material takes to burn. |
| Antiviral Activity (BS ISO 18184−2019) | Property of any substance (chemical or otherwise) producing a modification of one of the elements of the virion structure which induces the latter’s inability to replicate. | The test is conducted by comparing the reduction rate of virus between specimen and remaining infectious virus. Plaque assay and TCD50 methods are available to quantify the infectious virus tire. |
Fig. 2(a) Diagram of the structure of a surgical mask. (b) Digital photo of the PP melt-blown cloth. (c) SEM image of melt-blown PP fibers. (d) Observation of static charge on the surfaces of melt-blown PP filters. Reproduce with permission from [64]. Copyright 2020, ACS Applied Nano Materials. (e) Schematic diagram of the filtering functions of the three layer.
Fig. 3Filtration mechanism of fiber filter based on the particle size. Reproduced with permission from [65]. Copyright 2019, ACS Applied Nano Materials.
Fig. 4(a) Comparison of electrospun fiber and PP fiber. (b) SEM image of cross-section of nanofibers on a polyester spun-bond substrate. Reproduced with permission from [78]. Copyright 2003, International Nonwovens Journal.
Fig. 5(a) Schematic diagram of electrospinning technology. (b) SEM images of electrospun nanofibers with different geometries and styles. Reproduced with permission from [81]. Copyright 2020, Advanced Fiber Materials. (c) Structure of commonly used masks. (d) The proposed structure of electrospun ultrafine fibrous masks.
The manufacturability of bioactive electrospun nanofibers.
| Polymer type | Polymer features | Applications | Bioactivity of electrospun nanofibers | Manufacturability |
|---|---|---|---|---|
| Poly(vinyl alcohol) (PVA) | Nontoxic, biodegradable, water-soluble and biocompatible. | Immobilization of α-amylase in ultra-fine (PVA) fibers [ | Immobilized enzyme in PVA fibers showed greater enzymatic activity than the free form and Larger stability at extreme temperature/ PH. | √Blend electrospinning; |
| √Good production capacity; | ||||
| √Morphological fiber change: flatter and thicker; | ||||
| √No bead. | ||||
| Encapsulation of gallic acid into PVA fibers. [ | High antioxidant activity and great thermal resistance > 200 °C. | √Blend electrospinning; | ||
| √Good miscibility between gallic acid and PVA; | ||||
| √Diameters of the electrospun fibers increase with more loaded gallic acid. | ||||
| Poly(ethylene oxide) (PEO) | Water-soluble and low toxic; | Encapsulation of T4 bacteriophage in electrospun PEO/cellulose diacetate fibers. [ | Rapid phage release due to hydrophilic polymer shell; | √Coaxial electrospinning; |
| Appropriate for co-electrospinning with proteins and charged polysaccharides. | Reduced phage release profile for PEO molecular weight. | √Increase of fiber diameter with PEO molecular weight added; | ||
| √Morphology of post-release fiber: from discontinuous to minimally swollen; | ||||
| √Improvement of potential electrospinning as the change of the physical and electrical conductivity characteristics. | ||||
| Bioative glass | Excellent bioactivity, osteoconductivity, and osteoinductivity. | Electrospun nanofibers of antibacterial bioactive glass/PEO for wound healing. [ | Significant cell proliferation (82%) in a period of 24 h; | √Blend electrospinning; |
| Almost two times of antibacterial activity. | √Optimum rheological properties: ethanol:water (70:30), bioactive glass(BG) sol: BUTVAR® B-72 solution v/v(3:2). | |||
| Polyvinylpyrrolidone (PVP) | Low toxic, hydrophyl, good-adhesion and biocompatible. | Encapsulation ofβ-carotene within electrospun PVP nanofibers. [ | Maintained the antioxidant activity after the nanoencapsulation. | √Blend electrospinning; |
| √High processable; | ||||
| √The average diameters of PVP/β-carotene: 176–306 nm; | ||||
| √The average diameter increases with precursor solution increases. | ||||
| But the electrospinning failed at precursor solution of 12 wt.% PVP. | ||||
| The anti-bacterial effect of | The prepared electrospun nanostructures showed great biocompatibility, biodegradability, anti-bacterial and anti-viral activity. | √Blend electrospinning; | ||
| √The average diameters of the composite fibers increase with the increase of the percentage of Aloe vera, but the fiber became finer with the increase of Aloe vera acetate. | ||||
| Poly(lactic acid) (PLA) | Biocompatible, non-toxic, linear aliphatic thermoplastic polyester. Biodegradable, and soluble in organic solvents. | Electrospun PLA-chitosan core-shell nanofibers. [ | Two-stage release behavior of curcumin drug: an initial burst release followed by a sustained release. | √Coaxial electrospinning; |
| √Bead-free smooth fibers with an average diameter of 671 ± 172 nm and a broad diameter distribution. | ||||
| Poly (ε-caprolactone) (PCL) | Biocompatible aliphatic polyester, low melting point and high decomposition temperature. | Encapsulation of carvacrol within starch or PCL electrospun nanofibers. [ | Encapsulation efficiency (EE) enhanced with the polymers concentration; | √Blend electrospinning; |
| Specific bioactive functionality needs to be discussed further. | √Nanofibers formed mainly with PCL, while beads were obtained with starch systems; | |||
| √Tightly adhered electrospun layers: highest PCL concentration (15%) and CA ratio (15%). | ||||
| Thermoplastic carboxymethyl cellulose (TCMC) | Soluble in a vast variety of solvents, high modulus, adequate flexural, plus good tensile strength. | Drug carriers with electrospun nanostructures of TCMC with PEO. [ | The nanofibers were non-toxic; | √Coaxial electrospinning. |
| Slow and sustained drug release; | √Fiber morphology: smooth and beadles. | |||
| Excellent bactericidal activity against a wide range of bacteria. | ||||
| Chitin | Non-toxic, biocompatible, biodegradable polymer with limited solubility, high molecular weight and low chemical reactivity. | Electrospinning ofβ-chitin extracted from cuttlefish bone. [ | Have great potential as nanomaterials for wound healing. | √Blend electrospinning; |
| √Remarkable increase of electrospinnability when β-chitin was blended with PEO; | ||||
| √The diameter of nanofibers and thickness of the nanofibrous web reduced after the elimination of PEO. | ||||
| Chitosan (CS) | Biodegradable and biocompatible with antibacterial properties. | Preparation of resveratrol loaded chitosan:gellan (CS:Gel) nanofibers (NFs). [ | Higher antioxidant activities; | √Blend electrospinning; |
| Similar cytotoxicity against HT29 cancer cells with compared to free resveratrol. | √Addition of Gel (0.125 and 0.25% w/v) improved the electrospinning process and the quality of NFs, but more increase had negative effect on the spinnability of solutions and morphology of fibers; | |||
| √The diameter of fibers at 90:10 of CS:Gel solutions was significantly increased to 291 ± 41 nm. | ||||
| Starch | Biocompatible, biodegradable, and mucoadhesive | Electrospun nanofibers of native and anionic corn starch. [ | Potential as carriers for active components in food and packaging applications. | √Blend electrospinning |
| √Hard to electrospinning because of its branched amylopectin structures; | ||||
| √Increase of homogeneous and less beaded structures generated by anionic Hylon V; | ||||
| √The fibers are smooth with amylose contents of <70% (w/w). | ||||
| Pullulan (PUL) | Water soluble, non-toxic, non-immunogenic, non-mutagenic, and noncarcinogenic polymer. | Electrospun chitosan/pullulan nanofibers for drug delivery. [ | Fast dissolving oral films (FDOFs) exhibit excellent thermal stability and fast solubility. | √Blend electrospinning; |
| √High electrospinnability; | ||||
| √The diameter of nanofibers decreased initially then increased with the increase of chitosan; | ||||
| √Electrospinning process decreased the crystallinity of materials. | ||||
| Cinnamon Oil | Natural insecticide, volatile. | Antibacterial and antifungal properties and acaricidal effect against house dust mites of core/sheath structured electrospun nanofibers cinnamon oil/PVA. [ | The antibacterial and antifungal properties, potential acaricidal effect on house dust mites. | √Emulsion electrospinning; |
| Continuous release of functional ingredients over 28 days. | √Number of beads increased and diameter increased with increase of the concentration of PVA. | |||
| √The best conditions for smooth fiber with even fiber size distribution: solution feed rate of 0.2 mL/h, a voltage of 25 kV, and a tip-to-collector distance of 20 cm through a 23-gauge. | ||||
| Whey protein (WP) | Antioxidant, anti-cancer, antidiabetic, anti-obesity and cardio-protective activities. | Electrospinnability of WP isolate (WPI)/soy protein isolate (SPI) mixed with maltodextrin. [ | Need to be further discussed. | √Needleless electrospinning; |
| √Spinnability of maltodextrin-soy protein isolate blends was low; | ||||
| √Removal of the insoluble SPI fraction improved spinnability of the spinning dispersion; | ||||
| √Protein content was linked to the spinnability and fiber appearance. | ||||
Fig. 6The comparison of filtration performance of electrospun ultrafine fibrous filters, N95 respirators and commonly used surgical facemasks.
Fig. 7(a) Reusability of the TPU-10 nanofiber filter. Reproduced with permission from [115]. Copyright 2019, Nanoscale Research Letters. (b) and (c) SEM images showing nanofibers of the PBI filter before and after the cleaning process using inorganic particulate matters. Reproduced with permission from [116]. Copyright 2019, ACS Applied Materials and Interfaces. (d) Structure of the R-TENG. (e) Digital photo of the SEA-FM. (f) Durability test on the removal efficiency of the SEA-FM after 30 days. Reproduced with permission from [118]. Copyright 2018, ACS Applied Materials and Interfaces. (g) Photographs and SEM images of the MF sponge (red) and the ILP@MF filter (blue). (h) Filtration efficiency of the charged [C4mim][OAc]–PVP@MF filter regenerated for 1–10 times. Reproduced with permission from [119]. Copyright 2020, Nature Communications. (i) The schematic of the working mechanism of self-powered smart masks. (j) The proposed self-powered smart mask (1-inner layer, 2-middle layer, 3-smart layer). Reproduced with permission from [120]. Copyright 2020, arXiv:2005.08305. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).
Fig. 8(a) SEM image of PA6 electrospun nanofibers that thermally bonded onto the viscose non-woven. Reproduced with permission from [123]. Copyright 2012, Journal of Nanomaterials. (b)The percent conversion of GD nerve agent with PVDF composite samples. Reproduced with permission from [124]. Copyright 2018, ACS Applied Materials & Interfaces. (c) SEM image of 7.3 wt% SiO2@PTFE. (d) Schematic illustration of porous structure and breathability of BLNFMs. (e) Breathable performance of BLNFMs. (f) Self-cleaning performance of the superhydrophobic BLNFMs. Reproduced with permission from [126]. Copyright 2018, Applied Surface Science. (f) FE-SEM image show the cross section view of MN6C. Antibacterial activities of (g) Staphylococcus aureus and (h) Escherichia coli. A-UC, B-N6C, and C-MN6C. Reproduced with permission from [128]. Copyright 2014, Nano-Micro Letters.
Fig. 9(a, b) Copper3D NanoHack mask. (c,d) HEPA mask design with a box for filter insertion. Reproduced with permission from [135]. Copyright 2020, International Journal of Oral and Maxillofacial Surgery. (e) The 3D-printed adaptor on reusable elastomeric respirators. Reproduced with permission from [136]. Copyright 2020, Anaesthesia.
Fig. 10(a) Photographs of PDMS/PMMA-chitosan transparent air filter with different optical transmittance. (b) PM 2.5 and PM 10 removal efficiency of transparent filters with different transmittances. Reproduced with permission from [138]. Copyright 2019, iScience. (c) The prepared transparent air filter was integrated into the wing of a dragonfly model to observe its transmittance in front of a cloth sunflower. (d) Comparison of the removal efficiency between plain weave (PW), herringbone (HB), lozenge stria (LS) pattern of the fibrous membranes. Reproduced with permission from [137]. Copyright 2020, RSC Advances. (e) The transparent Hello Mask. Reproduced with permission from [140]. Copyright 2020, https://www.empa.ch/web/s604/schutzmaske.
Fig. 11SEM images of fouled PVA/CNCs filters (a) before (b) after water washing. Reproduced with permission from [143]. Copyright 2020, Chemical Engineering Journal. (c) Schematic showing the final shape and internal structure of the fully bio-based facemasks. Reproduced with permission from [144]. Copyright 2020, Science of the Total Environment.
Fig. 12Photos of the prototypes of NNF (a) type-A and (b) type-B: the frames fabricated by using a 3D printer and then a pair of hybrid filters were installed. Reproduced with permission from [147]. Copyright 2018, Aerosol and Air Quality Research.